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Objective: To compare the use of Bone Marrow adult Stem Cells (BMSCs), differentiated
in  vitro into osteoblasts, associated to calcium phosphate versus autogenous bone graft,
in  the repair process of critical size bone defects.
Materials and method: On 36 Wistar adult rats, bilateral full-thickness defects on parietal bone
were created. The defects were either repaired with calcium phosphate (group I), calcium
phosphate + (BMSCs) (group II) or autogenous bone graft (group III), and the opposite side
with blood clot (Control Group). In all cases a collagen membrane was used. The animals
were sacriﬁced at 30 and 60 days, and all specimens were collected for further histological
and  histomorfometric study.
Results: At 30 days, group III (autogenous bone graft) evidences a statistical difference on
bone formation when compared to the experimental and control groups (p ≤ 0.05). At 60
days  group II (BS + BMSCs) and group III (autogenous bone) showed a similar bone formation
and  has only a statistical difference when compared to group I (BS) and control group.
Conclusion: The use of calcium phosphate in conjunction with BMSCs resulted in a sim-
ilar  behavior in the process of bone repair in critical size defects, when compared with
autogenous bone graft.
© 2013 SECOM. Published by Elsevier España, S.L.U. All rights reserved.
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Estudio  comparativo  sobre  regeneración  ósea  en  defectos  óseos  craneales
con  células  madre  adultas  de  la  médula  ósea  y  fosfato  cálcico
(BoneSource®)
Palabras clave:
Médula ósea
Células madre
Regeneración ósea
r  e  s  u  m  e  n
Objetivo: Comparar el uso de células madre adultas de la médula ósea (CMMO), diferenciadas
in  vitro en osteoblastos, asociadas a fosfato cálcico, frente a injerto de hueso autólogo, en el
proceso de reparación de defectos óseos de taman˜o crítico.
Material y Método: En 36 ratas adultas Wistar, se crearon defectos bilaterales de todo el grosor
en  el hueso parietal. Los defectos se repararon con fosfato de calcio (BoneSource®) (grupo
I),  fosfato de calcio (BoneSource®) + (CMMO) (grupo II) o injerto de hueso autólogo (grupo
III), y en el lado contralateral con coágulo de sangre (grupo de control). En todos los casos
se  utilizó membrana de colágeno. Los animales fueron sacriﬁcados a las 30 y 60 días y se
obtuvieron todas las muestras para el estudio histológico y el análisis histomorfométrico.
Resultados: A los 30 días, en el grupo III (injerto de hueso autólogo) se puso de maniﬁesto
una diferencia estadísticamente signiﬁcativa en la formación de hueso en compara-
ción con el grupo experimental y el de control (p < 0,05). A los 60 días, en el grupo II
(BoneSource®) + CMMO) y el grupo III (hueso autólogo) se demostró una formación ósea
similar, y sólo se evidenció una diferencia estadísticamente signiﬁcativa en comparación
con  el grupo I (BoneSource®) y el grupo de control.
Conclusión: El uso de fosfato de calcio en combinación con CMMO indujo un comportamiento
similar en el proceso de reparación ósea en defectos de taman˜o crítico, en comparación con
injerto de hueso autólogo.
© 2013 SECOM. Publicado por Elsevier España, S.L.U. Todos los derechos reservados.
Introduction
The reconstruction of severe bone defects represents a
challenge for the surgeon. These defects are common in
patients who  have suffered severe trauma, tumor resections
or congenital deformities.1,2 The gold standard treatment
is the autogenous bone graft, but the main complications
are: morbidity at the site of the second surgery and the
limited amount of bone available.2–4 Recently the use of
minimal invasive techniques has been reported to show
decreased morbidity at the primary operative site. Many
materials have been tested to avoid the graft donation
surgery; the most common material used in reconstruc-
tions is calcium phosphate cement (BoneSource®), a mixture
of tetracalcium phosphate (TTCP) and dicalcium phos-
phate anhydride (DCPA). Investigations have shown that
calcium phosphate cement, like other heterogeneous mate-
rials, provides two elements required for bone regeneration
[osteoconduction and osteoinduction] but does not have
osteogenic properties.5–9 Currently, the use of tissue engineer-
ing techniques can be used to make bones with these three
elements and eliminate the morbidity of the donor graft col-
lection site.3,10,11
The goal of this study was to compare the use of Bone
Marrow Adult Stem Cells (BMSCs), differentiated in vitro into
osteoblast, used in conjunction of calcium phosphate versus
autogenous bone graft, in the process of repairing critical size
bone defects.
Materials  and  methods
Animal  model
54 male, adult, Wistar rats (age 120 days; weight, 25 kg) were
used for this experiment. The study was performed in agree-
ment, with the regulations and approval of the Institutional
Animal Care and Use Committee of the Federal University
of Pernambuco-Brazil and according to the standards of the
Laboratory Animal Care Assessment and Accreditation Asso-
ciation under number No. 019687/2006-72. The animals were
housed for 1 week, for them to become acclimatized to their
new housing and diet. Throughout the experiment, the rats
were monitored for general appearance, activity, excretion,
and weight.
72 full-thickness parietal bone defects of 5 mm in diam-
eter were created bilaterally on 36 Wistar adult rats, 2 in
each rat. On the same animal the defects were either repaired
with calcium phosphate cement (BoneSource®) – group I, cal-
cium phosphate cement and Bone Marrow adult Stem Cells
(BoneSource®) + (BMSCs) – group II, or autogenous bone graft
– group III, and the opposite side was treated with a blood
clot (Control). Animals were sacriﬁced at 30 and 60 days (6
out of each group) after the surgery and all specimens were
harvested for histological and histomorphometric studies, to
assess differences in healing and bone formation between
groups.
The collection of bone marrow was made twelve days prior
to the surgery, the graft was taken from 18 donor rats’ tibias
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and femurs, at a rate of 3–2, based on reported values of 6 and
9 × 106 cells/cm3. First of all the animals were anesthetized
with hydrochloride xylazine and ketamine hydrochloride,
then sacriﬁced with intracardiac potassium chloride. To col-
lect the marrow, the bones were cut at the height of the
epiphysis, so that the shafts remained intact and therefore
allow for medulla recollection. This was performed directly
in a sterile conical Falcon tube of 15 ml  with a needle of
18G × 11/2′′, using Heparin 1:10 in 0.1 M PBS, pH 7.2. After com-
pleting the collection, stem cells were separated on a Ficoll
gradient, under centrifugation at 450 turns for 30 min.
The top layer of stem cells above the Ficoll was sucked
through an automatic pipette and placed in a sterile conical
tube (Falcon, 50 ml). These cells were then washed in PBS, cen-
trifuged under 450 rounds for 10 min. After centrifugation, a
precipitate that represents the cells was obtained by discard-
ing the supernatant. The separate cells were resuspended in
1 ml  of Dulbecco Modiﬁed Eagle Medium (DMEM) with a high
rate of glucose (Invitrogen®), supplemented with 10% fetal calf
serum (Invitrogen®) and antibiotic/antimycotic (Ampicillin 1 g
Invitrogen®). We  obtained an aliquot of 10 l of cell counts,
which was suspended in 90 l of Trypan blue (1:10) and then
carried out in a Neubauer chamber, and the result adjusted to
106 cells/ml.
Stem cells were grown in 25 cm2 culture bottles, for 12 days
in a humidiﬁed incubator with 5% CO2 in sterile conditions.
The acquisition of mesenchymal stem cells was through the
adhesion of adult stem cells to the bottom of culture ﬂask. The
exchange of culture medium was performed every three days
and until the tenth day (Fig. 1), when the cultures reached
a conﬂuence of 80–90%, they were induced to differentiate
into osteoblasts phenotypically by the addition of an induc-
tion medium containing 100 nmol/l dexamethasone, 10 nmol/l
-glycerophosphate and 50 g/ml of ascorbic acid (Fig. 1).
At day 12, osteoblasts were removed from the bottle with
5 ml  of Trypsin–EDTA (0.05%) washed in PBS and added to a
sterile sodium chloride (NaCl) 0.9% solution, a concentration
of 106/10 l NaCl (Fig. 2).
The calcium phosphate cement (BoneSource®) was divided
into sterile plastic tubes (Eppendorf) each one containing
0.25 g of the powder, and was separated for the animals where
the material would be tested.
Before the trichotomy was performed, antisepsis of the
craniofacial region of the rat was carried out. Local anes-
thesia was obtained with local inﬁltration of 0.2 ml  lidocaine
hydrochloride at 2% with epinephrine concentration of
Fig. 1 – Stem cells culture. The exchange of culture medium
was performed every three days until the tenth day.
1:100,000 in order to decrease bleeding in the trans-operative
and encouraging greater comfort in the immediate postopera-
tive. Then an incision was made in the skin and periosteum
of the cranial region making a full thickness ﬂap, after the
skull exposition, two full-thickness, circular bone cavities
were made in the central region of each parietal bone, using
a trephine drill of 5 mm in diameter. Finally the bone frag-
ment was gently removed with a Lucas curette. The bone
perforations were carried out while constantly irrigating with
physiological solution of sodium chloride 0.9%, thus avoiding
the overheating of bone. Defects were ﬁlled at random accord-
ing to the group (Fig. 3).
Group  I
The test cavity was ﬁlled with calcium phosphate cement
(BoneSource®). The material was prepared with the calcium
monophosphate (liquid and powder) and gets mixed up to
form a uniform paste.
Group  II
The test cavity was ﬁlled with powder of calcium phosphate
cement (BoneSource®) associated with Bone Marrow adults
stem cells (BMSCs), differentiated in vitro in osteoblast. (It was
Fig. 2 – When the cultures reached a conﬂuence of 80–90%, they were  induced to differentiate into osteoblasts
phenotypically.
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Fig. 3 – Initial surgery procedure.
Fig. 4 – Filled defects randomly according to the Group.
mixed up the cement powder of BoneSource ®) and 10 micro-
liters of suspension containing one million (1 × 106) of cells
approximately).
Group  III
In this group the bone fragments removed with the trephine
drill were placed in the cavity (Fig. 4).
In all cases a collagen membrane was used to avoid migra-
tion of materials and any interference of the periosteum on the
regeneration process. Finally the wound was sutured (Fig. 5).
Fig. 5 – Final surgery procedure.
Histological  analysis
Three pathologists accomplished the histological analysis. All
the researchers were university professors in tissue and bone
lesions analysis. The three assessors had limited knowledge
about the methodology of this experiment, not knowing which
was the group or cavity to be evaluated.
For the evaluation of the samples the plates were delivered
in boxes labeled with HE staining and TM.  Additionally each
judge was handed a folder containing a standardized form,
categorized as *1 = present and *2 = absent. The histological
parameters used were: osteoid, immature bone, mature bone,
newly formed vessels, granulation tissue, collagen ﬁbers,
ﬁbroblasts, osteocytes, osteoclasts, osteoblasts, and inﬂam-
matory inﬁltrate implanted material. The item inﬂammatory
inﬁltrate was categorized as *0 = absent, *1 = acute, *2 = chronic.
Histomorphometric  analysis
The evaluation and quantiﬁcation of newly formed bone tissue
was performed at the Faculty of Dentistry, Bahia Foundation
for the Advancement of Science, in Salvador Bahia, through
the use of the program Motic Images Advanced 3.0 (Micro-
Optic Industrial Group Co. Ltd.) compatible with Windows XP
operating system. Initially, the sections stained with HE were
examined with a light microscope with an increase of 4 and
10× to ensure complete visualization of the original defect,
then being captured by digital camera attached to the micro-
scopic system Motic Images Advanced 3.0 and displayed on
the computer monitor and were captured in slide images at 4,
10 and 40×.  Progressive numbering sorted by operators who
participated directly in the research but without knowing to
which group it belonged performed the capture of images on
the blades.
Results
This study showed that the defect of 5 mm in the calvar-
ial bone formation was limited to the margins of the defect
without revealing spontaneous bone regeneration after 4 or
8 weeks of surgery (Fig. 5).
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Table 1 – Histomorphometric evaluation of the difference between test and control groups.
Evaluation time Tested material p value
BoneSource® BoneSource® + BMSCs Autogenous bone graft
Mean ± SDa Mean ± SDa Mean ± SDa
30 days 8175.03 ± 2410.57(A) 9780.78 ± 2162.63(A) 13658.18 ± 2082.97(B) pb = 0.002*
60 days 10838.85 ± 1045.22(A) 13615.30 ± 1422.79(B) 13294.89 ± 1437.25(B) pb = 0.004*
p value pc = 0.032* pc = 0.005* pc = 0.732
Comments: If all the letters in parentheses are different statistical signiﬁcance differences exist between materials.
a SD = Standard Deviation.
b Statistical test F (ANOVA) with Tukey comparisons in case of Statistical signiﬁcance.
c Through test t-Student.
∗ Statistical signiﬁcance 5.0%.
The time working with both, the sodium monophosphate
and the solution containing osteoprogenitor cells, was enough
for proper handling of the material, allowing an execution
without major technical difﬁculties. Surgical time did not
increase due to the manipulation of the suspension of osteo-
progenitor cells.
The bone formation in experimental groups was always
higher than control groups, which were ﬁlled with blood clot.
In periods of 30 and 60 days there was a signiﬁcant difference
between all the materials and the control group (p ≤ 0.001). In
control group the media in bone formation were similar in all
groups and periods of sacriﬁce, showing no bone formation
(Table 1).
When new bone formation was compared between the
three experimental groups, it was observed that the period
of 30 days in group III (autogenous bone) had the high-
est average of new bone formation when compared with
the other two groups (19805.58 ± 1507.94), with a signiﬁ-
cant difference at p ≤ 0.001. Also in this period of sacriﬁce,
group II (cement + CT) had a higher average than group
I (cement) but no signiﬁcant difference between both
(16293.02 ± 1140.50 > 14981.32 ± 1837.72). When comparing the
averages in the second period of sacriﬁce (60 days) both group
II and group III had similar average with a higher bone forma-
tion when compared to group I, with a signiﬁcant difference
at p ≤ 0.004. This period of sacriﬁce in group II had a higher
mean than group III, but no signiﬁcant difference between
both materials (Table 2 and Fig. 6).
Discussion
The calcium phosphate cement (BoneSource®) has been
widely used to repair defects in the craniofacial region, its use
began in 1997 when the Food and Drug Administration (FDA)
approved its application, the ﬁrst such material available for
use, being tested in clinical presentations in multiple studies.
It is an osteoconductive material in its pure form that is con-
verted into hydroxyapatite cement, with the same properties
found in natural bone, but it does not have osteoprogenitor
cells.12–14
This material was chosen for this study due to its many
properties; its presentation (liquid and powder) makes it is
easy to handle, it has excellent biocompatibility in the liter-
ature and market availability. In most studies of stem cells
associated with the ﬁlling materials the ones commonly cho-
sen were coral scaffolds or hydroxyapatite, mainly because
the goal was to assess bone formation within the pores of the
framework. In this study we  used calcium phosphate cement
(BoneSource®) due to which our goals were met  by the clin-
ical application of this technique, in cases were ﬁlling would
Table 2 – Histomorphometric evaluation of tested material and time of sacriﬁce.
Evaluation time Group Tested material p value
BoneSource® BoneSource® + BMSCs Autogenous bone graft
Mean ± SDa Mean ± SDa Mean ± SDa
30 days Control 6809.29 ± 1826.41 6512.24 ± 1294.02 6147.40 ± 804.72 pb = 0.713
Tested 14981.32 ± 1837.72(A) 16293.02 ± 1140.50(A) 19805.58 ± 1507.94(B) pc = 0.001*
p value pc = 0.001* pc = 0.001* pc = 0.001*
60 days Control 6946.33 ± 1577.91 6689.71 ± 1392.30 7579.19 ± 1147.98 pb = 0.533
Tested 17785.18 ± 1873.33 20305.01 ± 1132.11(B) 20874.07 ± 996.47(B) pb = 0.004*
p value pc = 0.001* pc = 0.001* pc = 0.001*
Comments: If all the letters in parentheses are different Statistical Signiﬁcance differences exist between materials.
∗ Statistical signiﬁcance 5.0%.
a SD = Standard Deviation.
b Statistical test F (ANOVA) with Tukey comparisons in case of statistical signiﬁcance.
c Through test t-Student.
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Fig. 6 – Images of histomorphometric analysis.
required it would be much more  feasible and economical than
the construction of scaffolds by default.
Contrary to what may be led to believe by this clinical trial,
the surgery time has not increased due to the manipulation
of osteoprogenitor cell suspension, which leads us to believe
that its clinical application shall not increase the costs due to
the need for a prolonged surgical procedure in reconstructing
bone.
With the histological results of three evaluators, a Kappa
test was performed to assess the level of agreement in the
answers between pairs of examiners. Based on the results
the examiners were calibrated because only two items for the
evaluation has a different result among them.
About the calcium phosphate cement in this study, we
observed that, between weeks 4 and 8, the presence of mul-
tinucleated giant cells was a constant ﬁnding and location of
these cells was always close to the particles of the material.
The decaling process for preparing the specimen for histolog-
ical evaluation left a space corresponding to the particle of
calcium phosphate cement and it was possible to identify the
inﬂammatory inﬁltrate in the vicinity of these spaces. These
ﬁndings are consistent with reports from Indovina Jr and Block
(2002)15 who  observed an inﬁltration of mononuclear cells and
multinucleated giant cells around areas related to the parti-
cles of the implanted material, even after a period of 8 and
12 weeks after surgery.
The bone formation in experimental groups of this study
was always higher in the test cavities receiving a ﬁlling mate-
rial than in control cavities that were ﬁlled with blood clot from
the animal itself. In periods of 30 and 60 days there was no sig-
niﬁcant difference between all the materials and the controls
(p ≤ 0.001). The bone formation average in the control groups
remained similar in all groups and periods of sacriﬁce, show-
ing that nobone formation in critical defects, in agreement
with literature reports.6,16 Groups I and II showed a signiﬁcant
difference in bone formation, when we compared the main
differences in histomorphometry between groups and the two
sacriﬁce periods, as in group III this value was similar in both
periods showing the same behavior during the treatment.
When the new bone formation was compared between
the 3 groups, we  observed that the period of 30 days in
group III (autograft) had the highest average of new bone for-
mation when compared with the other two groups with a
signiﬁcant difference. Also in this period of sacriﬁce, group
II (cement + CT) had a higher average than group I (cement)
but there was no signiﬁcant difference between them. When
comparing the averages in the second period of sacriﬁce (60
days) it was found that both group II and group III had simi-
lar medium with a higher bone formation when compared to
group I, with a signiﬁcant difference. This period of sacriﬁce
group II had a higher average than group III, but no signiﬁcant
difference between both materials. These results can be com-
pared with literature reports, where there was bone formation
in regions treated with stem cell culture.3,17–19
Several works show the formation of bone tissue using cul-
ture of mesenchymal cells into scaffolds implanted in speciﬁc
or ectopic areas; a study published by Abukawa et al. in 200317
shows by the making a framework shaped condyle ﬁlled with
osteoprogenitor cells, and implanted on the backs of mice,
there was bone formation, but only on the surface and without
vascular formation. They concluded that more studies should
be performed to improve the penetration of cells in the scaf-
fold, and promote vascular formation. The following year the
same authors published a study where the protocol for stem
cell culture, the framework and time to deploy the material
was changed, trying to reach the bone formation in an even
way, and with central vascularization. They reached the goals
and concluded that mesenchymal cells derived from bone
marrow can be manipulated and when placed in an environ-
ment or framework can form a structure similar to the actual
bone.3
The results presented here may be related to these works
through a mixture of osteoprogenitor cells derived from bone
marrow mesenchymal cells associated with a vehicle such as
cement of calcium phosphate. We found bone formation in
defects ﬁlled with this material at 60 days. The material pre-
sented in average a greater bone formation than autologous
bone graft, but no signiﬁcant difference between the two, lead-
ing us to believe that this type of treatment may be the key to
success in tissue engineering regarding bone reconstruction,
apparently it also had the same characteristics as autograft.
Mesenchymal stem cells (MSCs) derived from bone mar-
row have been used in the repair of different tissues such
as cartilage or bone due to its ability to transform into spe-
ciﬁc cells after the culture in different medium, the use
of -glicerolfosfato and dexamethasone can improve the
osteogenic phenotype of these cells,10,19,20 but the need for
removal of large quantities of bone marrow for a few mes-
enchymal cells is a major problem in the cells obtained from
that source.
Studies published recently show that for every 100,000
cells obtained from bone marrow only one can be considered
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a mesenchymal cell, which indicates that only a limited
proportion of cells can be differentiated into osteogenic
lineage.21,22 In this work we  observed this complication and
later in the pilot study, we had intended to obtain cells from
one donor mouse to a recipient mouse, but the amount of
cells present was so low it was necessary to increase the
number of donor rats to 3, which generates a greater number
of dead animals, a greater number of materials used and a
much higher waste of time and money.
Solutions for this problem: several studies have been
recently published using cells derived from adipose tissue.23,24
In a report by Cui et al. in 2007,25 they repaired critical defects
in ice dogs by coral frameworks associated with the culture
of stem cells derived from body fat and concluded that there
was enough bone formation to be used in this cell type and
underlined it as an alternative source of abundant stem cells.
The bone in the maxillofacial region has a key role in
maintaining both the facial function and appearance. Facial
anatomy should be restored correctly when it becomes com-
promised by any pathology. The future in bone reconstruction
will apply predeﬁned scaffolds loaded with mature osteo-
progenitor cells and/or embryo cells cultured in vitro to
reconstruct maxillofacial defects and cover them entirely.
Conclusion
Bone marrow stem cells used in conjunction with a calcium
phosphate cement were similar to the gold standard autoge-
nous bone grafts in bone regeneration of critical size defects.
It provided the three elements required for bone regeneration:
osteoconduction, osteoinduction, and osteogenic cells.
We observed that the 5 mm critical size defects treated with
no material, i.e. blood clot, showed no bone regeneration as the
use of a collagen membrane avoided migration of material into
these control sites at 4 and 8 weeks post-surgery.
Surgical time was not altered by the use of stem cells in
conjunction with the calcium phosphate cement so its clinical
application will not require longer time periods compared to
conventional procedures.
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